All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Faron Pharmaceuticals

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

FINLAND Finland

Post An Enquiry

BIO International Convention

Participation Not Confirmed

Update your events

Faron receives grant from Business Finland

Contact the Supplier

Lead Product(s): Clevegen

Therapeutic Area: Oncology

Highest Development Status: Phase I/ Phase II Product Type: Large molecule

Partner/Sponsor/Collaborator: Business Finland

Deal Size: $0.8 million Upfront Cash: Undisclosed

Deal Type: Funding May 11, 2020

Details:

Grant will enable characterization of immunological responses in MATINS trial. Clevegen to be studied in experimental combinations with anti-cancer molecules from other consortium members.